• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.

作者信息

Nabid Abdenour, Souhami Luis

机构信息

Radiation Oncology, Centre Hospitaler Universitaire de Sherbrooke, Sherbrooke, Canada.

McGill University Health Centre, Montreal, Canada.

出版信息

Eur Urol. 2019 Mar;75(3):e63. doi: 10.1016/j.eururo.2018.10.029. Epub 2018 Oct 26.

DOI:10.1016/j.eururo.2018.10.029
PMID:30773206
Abstract
摘要

相似文献

1
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.对皮鲁斯·加贾尔和托马斯·维格尔致编辑的信的回复，信的主题为：阿卜杜勒努尔·纳比德、娜塔莉·卡里尔、安德烈 - 居伊·马丁等人。高危前列腺癌雄激素剥夺治疗的持续时间：一项随机III期试验。《欧洲泌尿外科杂志》2018年；74卷：432 - 431页。
Eur Urol. 2019 Mar;75(3):e63. doi: 10.1016/j.eururo.2018.10.029. Epub 2018 Oct 26.
2
Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.
Eur Urol. 2019 Mar;75(3):e61-e62. doi: 10.1016/j.eururo.2018.10.030. Epub 2018 Oct 26.
3
Reply to Pirus Ghadjar, Thomas Wiegel's Letter to the Editor re: Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome, Toxicity of Stereotactic Body Radiotherapy, Elective Nodal Radiotherapy. Eur Urol 2019;76:732-9.
Eur Urol. 2020 Mar;77(3):e62-e63. doi: 10.1016/j.eururo.2019.11.003. Epub 2019 Nov 16.
4
Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156-65: Salvage Radiotherapy and Hormone Therapy: Change Is Coming, Just Not Quite Yet.对皮鲁斯·加贾尔和托马斯·维格尔致编辑的信的回复，信的主题为：丹尼尔·E·斯普拉特、罗伯特·T·德丝、扎卡里·S·祖姆施泰格等人的《复发性前列腺癌挽救性放疗联合激素治疗的系统评价与框架》。《欧洲泌尿外科杂志》2018年；73卷：156 - 165页：挽救性放疗与激素治疗：变革即将到来，但尚未完全到来。
Eur Urol. 2018 Mar;73(3):e64-e65. doi: 10.1016/j.eururo.2017.10.006. Epub 2017 Oct 28.
5
Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.
Eur Urol. 2019 May;75(5):e131-e132. doi: 10.1016/j.eururo.2018.12.024. Epub 2019 Jan 4.
6
Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410-8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?
Eur Urol. 2019 Apr;75(4):e101-e102. doi: 10.1016/j.eururo.2018.11.034. Epub 2018 Nov 30.
7
Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD TrialUntil Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results.回复阿什温·辛德、理查德·李、阿莉亚·阿米尼和斯科特·格拉泽给编辑的信，信的内容涉及：利塞尔洛特·M·S·博埃夫、马腾·C·C·M·胡尔肖夫、安德烈·N·维斯等人。在一项前瞻性随机临床试验中，单纯雄激素剥夺疗法与雄激素剥夺疗法联合前列腺同步放射疗法对原发性骨转移性前列腺癌患者生存的影响：来自HORRAD试验的数据。《欧洲泌尿外科杂志》2019年；75卷：410 - 418页：转移性前列腺癌确定性治疗的未来步骤：来自HORRAD试验的经验教训 直到随机对照试验证明情况不同之前，治疗患者，而非其影像学结果。
Eur Urol. 2019 Mar;75(3):e71-e72. doi: 10.1016/j.eururo.2018.11.007. Epub 2018 Nov 22.
8
Reply to André Pontes-Silva's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70.回复安德烈·庞特斯 - 席尔瓦致编辑的信，内容涉及：加布里埃拉·伊利耶、里卡多·伦登、罗斯·梅森等人。一项为期6个月的前列腺癌患者综合赋权计划可减轻接受前列腺癌根治性治疗男性的心理困扰：一项随机临床试验。《欧洲泌尿外科杂志》2023年；83卷：561 - 70页。
Eur Urol. 2024 Feb;85(2):e45-e46. doi: 10.1016/j.eururo.2023.08.027. Epub 2023 Sep 22.
9
Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.回复：利塞尔otte M.S. 博埃夫、马尔滕 C.C.M. 胡尔绍夫、安德烈 N. 维斯等。前瞻性随机临床试验中，单纯雄激素剥夺疗法与雄激素剥夺疗法联合同期前列腺放疗对原发性骨转移性前列腺癌患者生存率的影响：HORRAD试验数据。《欧洲泌尿外科杂志》2019年；75卷：410 - 418页。
Eur Urol. 2019 May;75(5):e129-e130. doi: 10.1016/j.eururo.2018.12.025. Epub 2018 Dec 24.
10
Reply to Bernard Tombal's letter to the editor re: Alessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al. Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials. Eur Urol 2013;64:722-30.对伯纳德·通巴尔致编辑的信的回复，信的主题为：亚历山德罗·夏拉、佩尔·安德斯·亚伯拉罕松、毛里齐奥·布劳西等人所著《前列腺癌的间歇性雄激素剥夺疗法：聚焦于3期试验的批判性综述》。《欧洲泌尿外科杂志》2013年；第64卷：722 - 730页
Eur Urol. 2014 Apr;65(4):e57. doi: 10.1016/j.eururo.2013.12.015. Epub 2013 Dec 21.

引用本文的文献

1
Diagnosis of advanced prostate cancer at the community level in Rwanda.卢旺达社区层面的晚期前列腺癌诊断。
Int Urol Nephrol. 2021 Oct;53(10):1977-1985. doi: 10.1007/s11255-021-02921-8. Epub 2021 Jun 30.